Standard Process Heart and Gut Health Study

Inclusion Criteria: * Healthy participants (both male and female) aged 25-80 years with omnivorous diet (regular consumption of eggs, red meat, dairy) * No pre or probiotic consumption during study, no antibiotics during study * Moderate to high serum levels of TMAO (more than or equal to 4 uM) determined by a standard blood test * If the participant is on antibiotics, they should finish their medication and wait one month before testing for TMAO as a screening criterion * Normal blood pressure, non-smokers * Normal cholesterol * Participants can communicate and follow instructions * Participants voluntarily signed and dated an informed consent (ICF), reviewed by an Institutional Review Board (IRB), and provided authorization prior to any participation in the study * Participants who are willing to take nutritional supplements and have no known food allergies Exclusion Criteria: * Vegan and vegetarian participants * Participants on medically prescribed diet * Participants not willing to stop consumption of fermented products (plain yogurt, kefir, kombucha, water kefir, miso, pickled vegetables, and sauerkraut) 2 weeks prior to the study start date and during the study timeline as this will interfere with gut microbiome related outcome assessment * Participants not willing to stop consuming polyphenols- green tea, cocoa, flaxseed, berries, and energy drinks * Participants who are currently or have participated in other interventional clinical trials in the last 4 weeks * Participants on certain supplements like GI health related (Probiotics, prebiotics, and/or antimicrobial botanicals), vitamin C, Choline, lecithin or L-carnitine, fish oil/krill oil containing supplements who don't wish to stop supplementation prior to 2 weeks of study start date * Participants who have any confirmed or suspected infectious disease (such as tuberculosis, Hepatitis B or C, HIV infection), malignancy, or any other clinically significant medical condition, which in the investigators' opinion, makes him or her not suitable for inclusion in the study\* * Participants who have pacemakers, an implanted cardioverter defibrillator (ICD), or a cardiac resynchronization therapy device * Participants who have confirmed or suspected pregnancy (self-reported) * Participant waiting for a heart transplant * Participants currently hospitalized for acute myocardial infarction * Participants with a planned revascularization within 30 days of screening * Participants must not have any allergies to supplement ingredients (see list) * Participants who have initiated the use of prescription medications (defined as a medication that can be prescribed only by a properly authorized/licensed clinician), and not authorized non-prescription medications (over-the-counter medications), and other nutritional supplements * Participants who do not comply with all study requirements (including clinical visits) * Participants with high cholesterol or on lipid lowering medications like statins * Participants on following medication: NSAIDS, Steroids, Prednisone, Acid Reflux/GERD medicines: Tagamet, Zantac, Pepcid, Prilosec, Prevacid